Long-Term Use of Bonviva® for the Treatment of Postmenopausal Osteoporosis: New Evidence
Osteoporosis is a disease of great social importance. Its treatment is a complicated problem and is associated with low compliance and a risk for adverse reactions. Ibandronate belongs to a group of bisphosphonates. The performed trials have proven the efficacy of its two formulations (a tablet once...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2013-02-01
|
| Series: | Bolʹ, Sustavy, Pozvonočnik |
| Subjects: | |
| Online Access: | http://pjs.zaslavsky.com.ua/article/view/81978 |